How Mexico Built a Legal Right to Grow Cannabis — One Lawsuit at a Time

A Right That Had to Be Demanded

In most countries, cannabis legalisation arrives — if it arrives at all — through legislation. A parliament votes, a law changes, a framework appears. Mexico took a different route. Its highest court declared the absolute prohibition of personal cannabis cultivation unconstitutional, then watched as an indifferent Congress did nothing. So citizens went to court themselves, one by one, to force the state to acknowledge what the judges had already decided.

The tool they used is called the amparo — a constitutional remedy unique to Latin American legal tradition, with no direct equivalent in European law. Understanding how it works, and what it achieved, offers an instructive case study for anyone interested in how legal systems can be pressed into service by individuals when legislatures stall.

What the Supreme Court Actually Said

The process began in 2015, when Mexico's Supreme Court ruled in favour of four members of a civil organisation, granting them the right to cultivate and consume cannabis personally. The legal foundation was not a health exemption or a medical licence — it was the constitutional right to the free development of personality, enshrined in Article 1 of the Mexican constitution. The ruling recognised that personal autonomy, not therapeutic need, was the relevant principle.

More rulings followed in the same direction. Under Mexican jurisprudence, five consistent Supreme Court decisions in the same direction create binding precedent. That threshold was reached. Still, Congress amended nothing. In 2021, the Court issued a General Declaration of Unconstitutionality — a formal instrument striking down the specific articles of the General Health Law that had allowed the federal sanitary authority, COFEPRIS, to refuse personal cultivation permits.

The practical consequence of that declaration is the part most people miss: from that point forward, COFEPRIS could no longer legally deny a permit to an adult who applied for one. The right was no longer theoretical. It was administrative.

When Bureaucracy Becomes the Obstacle

Here is where the amparo re-enters the picture. Since 2021, there has been a free administrative pathway: an adult can apply directly to COFEPRIS for a personal cultivation authorisation, presenting only basic identity documents — no medical diagnosis, no prescription, no therapeutic justification required. In straightforward cases, this is now the first and often sufficient step.

But bureaucracies do not always behave as the law demands. Applications are refused, ignored, delayed past their legal deadline, or simply not accepted at the counter. When that happens, the amparo indirecto — an indirect constitutional complaint filed before a federal administrative court — becomes the mechanism to compel compliance. The court, if it agrees the refusal was unlawful, orders COFEPRIS to issue the authorisation it withheld.

The amparo does not create the right — the Supreme Court already did that. It forces the administration to acknowledge it in a document with a name on it.

The procedural requirements are precise. An applicant must first exhaust the administrative route and, critically, retain written proof of the refusal. Without that documented denial, there is no formal act to challenge and the case collapses. If a refusal is received, a complaint must be filed within fifteen working days. Missing that window means restarting the administrative process from scratch.

Legal representation is not mandatory. Civil society organisations have circulated template filings that applicants can complete with their own personal details, and several associations accompany people through the process at no cost. Professional advice becomes more important if the court raises procedural objections or the case proceeds to an appeal.

Why This Model Is Worth Watching

There is a broader point here that extends well beyond Mexico's borders. What the amparo system illustrates is that rights, once established in principle by a high court, do not automatically become accessible. They must be operationalised — sometimes individually, case by case — against the institutional inertia of health agencies and regulatory bodies more comfortable with prohibition than with accommodation.

Europe is not Mexico, and the amparo has no direct European counterpart. But the underlying dynamic — a legal framework that formally permits something while administrative structures continue to obstruct it — is familiar enough on this side of the Atlantic. In several EU member states, medical cannabis is nominally accessible while patients report waiting months for approvals, encountering pharmacies that do not stock products, or navigating referral systems that function as practical barriers.

The Mexican experience suggests that when the law is on one's side and the administration lags behind, organised civil society and well-documented individual casework can close the gap. That is a transferable lesson, whatever the jurisdiction.

A Note on the Medical Distinction

One nuance from the Mexican case is worth flagging for readers in the healthcare and harm reduction space. Mexican medical cannabis regulation was designed around pharmaceutical products — extracted, processed, laboratory-manufactured. It does not contemplate the flower, nor consumption by inhalation. The personal cultivation authorisation obtained through the administrative or amparo route is, in practice, the only legal pathway to the plant in its natural form.

That distinction between the medical and personal-use legal tracks — with different products, different gatekeepers, and different underlying rights — is one that regulators and patients alike navigate in various forms across many jurisdictions. It is rarely as clean in practice as it appears in statute.

For now, Mexico's slow, contested, courtroom-by-courtroom normalisation of personal cannabis cultivation stands as one of the more unusual experiments in cannabis rights globally. Not the most straightforward path. But, for those who took it, a real one.

— Anna Micallef

Sources:
Revista THC — https://revistathc.com/amparo-para-cultivar-cannabis-en-mexico-como-tramitarlo-paso-a-paso/

Featured image: Photo by Mario Spencer on Pexels